| Investor Type | Firm |
| Investing | United Kingdom |
IBEX Innovations Limited, also known simply as IBEX, is a company that has pioneered advanced X-ray detector technology to deliver high sensitivity materials information from standard X-ray detectors. Founded by Dr. Gary Gibson in 2010 and gaining momentum in 2011 after securing venture-capital investment, IBEX has successfully transitioned its initial concept into fully engineered solutions.
Its technology is witnessing growing commercial adoption across various industries, including security, electronics, food inspection, and medical markets.IBEX's core mission is to support healthy aging by enabling routine access to osteoporosis diagnosis through its innovative bone health solutions.
The company’s flagship product, IBEX BH, utilizes X-ray imaging to automatically report fracture risks without requiring changes to existing system hardware or imaging protocols.
It has been validated in clinical studies and recognized for its potential in opportunistic screening, improving early diagnosis and management of osteoporosis.The highly skilled team at IBEX comprises scientists, engineers, and business professionals operating from modern facilities in NETPark, Sedgefield, UK.
Collaborating closely with academic and healthcare institutions, IBEX maintains partnerships with the Mathematics Department at Durham University for core technology development and works with the NHS Trusts to validate its medical imaging applications.Support from key investors like Northstar Ventures, IP Group, and Nordson Incorporated, alongside financial grants from InnovateUK and the European Commission, has propelled the development of IBEX’s technologies.
The company's advancements resonate with its commitment to innovation in medical diagnostics, contributing to the identification and prevention of bone-related health issues.









